| Name | Title | Contact Details |
|---|---|---|
Andrew Sherman |
Senior Director and Deputy Security Officer | Profile |
Darius Felton |
Chief Medical Information Officer - H H/Coney Island | Profile |
Kevin Lynch |
Senior Vice President and Chief Information Officer | Profile |
Vitamin Discount Center Incorporated is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.
Heron Therapeutics` Inc. (formerly A.P. Pharma` Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
RemedyMD is the leading provider of registries for life sciences. RemedyMDs highly specific patient and disease registry software and comparative effectiveness research tools enable researchers, clinicians and scientists to collect, aggregate, harmonize, and analyze data from widely disparate sources and then use RemedyMD tools and applications to identify patterns that result in accelerated discoveries, better patient outcomes, and advance translational research.
Caregiver's Home Companion is a Southport, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.